The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma

  1. Geier, A.
  2. Macias, R.I.
  3. Bettinger, D.
  4. Weiss, J.
  5. Bantel, H.
  6. Jahn, D.
  7. Al-Abdulla, R.
  8. Marin, J.J.G.
Revue:
Oncotarget

ISSN: 1949-2553

Année de publication: 2017

Volumen: 8

Número: 9

Pages: 15846-15857

Type: Article

DOI: 10.18632/ONCOTARGET.15029 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus